肿瘤细胞治疗研究
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov、CDE 与 ChiCTR 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Intraperitoneal immune microenvironment and efficacy of intraperitoneal chemotherapy in patients with gastric cancer and peritoneal metastasis.
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。